Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
Abstract
[INTRODUCTION] Component separation technique (CST) facilitates anterior fascial closure but can increase wound morbidity and alter abdominal wall anatomy. Preoperative Botulinum toxin A (BTA) relaxes the oblique musculature, potentially reducing CST. This study evaluated trends in CST utilization following the adoption of BTA.
[METHODS] A prospectively maintained database was reviewed for patients who underwent open AWR (2016-2024). Primary outcome was proportion of CST use over time; secondary analysis compared early (2016-2017) versus late (2023-2024) cohorts.
[RESULTS] Among 1484 patients (mean age 58.8 ± 12.3 years; BMI 31.0 ± 5.8 kg/m; defect size 211.5 ± 165.6 cm), fascial closure was achieved in 99.5%. CST decreased from 48.0% to 19.9% (OR: 0.88,95% CI: 0.813,0.946;p < 0.001). BTA increased (2.9% to 11.0%), though annual change was not significant (OR: 0.98,95% CI: 0.898,1.071;p = 0.670). Between early and late cohorts (n = 384 vs. 356), defect size was similar (219.1 ± 160.6 vs. 213.8 ± 181.3 cm;p = 0.367). There was a reduction in wound breakdown (6.5% vs. 0.8%) and recurrence (2.9% vs. 0.6%)(p < 0.05).
[CONCLUSION] Following the introduction of BTA, utilization of CST decreased and was accompanied by a reduction in wound morbidity.
[METHODS] A prospectively maintained database was reviewed for patients who underwent open AWR (2016-2024). Primary outcome was proportion of CST use over time; secondary analysis compared early (2016-2017) versus late (2023-2024) cohorts.
[RESULTS] Among 1484 patients (mean age 58.8 ± 12.3 years; BMI 31.0 ± 5.8 kg/m; defect size 211.5 ± 165.6 cm), fascial closure was achieved in 99.5%. CST decreased from 48.0% to 19.9% (OR: 0.88,95% CI: 0.813,0.946;p < 0.001). BTA increased (2.9% to 11.0%), though annual change was not significant (OR: 0.98,95% CI: 0.898,1.071;p = 0.670). Between early and late cohorts (n = 384 vs. 356), defect size was similar (219.1 ± 160.6 vs. 213.8 ± 181.3 cm;p = 0.367). There was a reduction in wound breakdown (6.5% vs. 0.8%) and recurrence (2.9% vs. 0.6%)(p < 0.05).
[CONCLUSION] Following the introduction of BTA, utilization of CST decreased and was accompanied by a reduction in wound morbidity.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 합병증 | wound
|
scispacy | 1 | ||
| 합병증 | abdominal wall
|
scispacy | 1 | ||
| 약물 | [INTRODUCTION]
|
scispacy | 1 | ||
| 질환 | AWR
|
scispacy | 1 | ||
| 질환 | BTA
→ Botulinum toxin A
|
scispacy | 1 | ||
| 기타 | abdominal wall
|
scispacy | 1 | ||
| 기타 | anterior fascial
|
scispacy | 1 | ||
| 기타 | Botulinum toxin A
|
scispacy | 1 | ||
| 기타 | oblique musculature
|
scispacy | 1 | ||
| 기타 | CST
→ Component separation technique
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | fascial
|
scispacy | 1 | ||
| 기타 | BTA
→ Botulinum toxin A
|
scispacy | 1 |
MeSH Terms
Humans; Botulinum Toxins, Type A; Middle Aged; Male; Female; Abdominal Wall; Neuromuscular Agents; Aged; Preoperative Care; Hernia, Ventral; Retrospective Studies; Abdominal Wound Closure Techniques
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.
- Chondrocyte proliferation without inflammation underlies botulinum toxin-induced mandibular enthesis bone hypertrophy in rats.